1. Home
  2. PHG vs BNTX Comparison

PHG vs BNTX Comparison

Compare PHG & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHG
  • BNTX
  • Stock Information
  • Founded
  • PHG 1891
  • BNTX 2008
  • Country
  • PHG Netherlands
  • BNTX Germany
  • Employees
  • PHG N/A
  • BNTX N/A
  • Industry
  • PHG Medical Electronics
  • BNTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PHG Health Care
  • BNTX Health Care
  • Exchange
  • PHG Nasdaq
  • BNTX Nasdaq
  • Market Cap
  • PHG 24.6B
  • BNTX 23.9B
  • IPO Year
  • PHG N/A
  • BNTX 2019
  • Fundamental
  • Price
  • PHG $26.05
  • BNTX $119.34
  • Analyst Decision
  • PHG Hold
  • BNTX Strong Buy
  • Analyst Count
  • PHG 4
  • BNTX 15
  • Target Price
  • PHG N/A
  • BNTX $143.50
  • AVG Volume (30 Days)
  • PHG 580.9K
  • BNTX 1.0M
  • Earning Date
  • PHG 02-03-2025
  • BNTX 11-04-2024
  • Dividend Yield
  • PHG N/A
  • BNTX N/A
  • EPS Growth
  • PHG N/A
  • BNTX N/A
  • EPS
  • PHG N/A
  • BNTX N/A
  • Revenue
  • PHG $20,119,339,720.00
  • BNTX $3,390,698,192.00
  • Revenue This Year
  • PHG $3.01
  • BNTX N/A
  • Revenue Next Year
  • PHG $4.34
  • BNTX N/A
  • P/E Ratio
  • PHG N/A
  • BNTX N/A
  • Revenue Growth
  • PHG N/A
  • BNTX N/A
  • 52 Week Low
  • PHG $19.55
  • BNTX $76.53
  • 52 Week High
  • PHG $32.91
  • BNTX $131.49
  • Technical
  • Relative Strength Index (RSI)
  • PHG 36.88
  • BNTX 56.35
  • Support Level
  • PHG $26.12
  • BNTX $116.73
  • Resistance Level
  • PHG $26.46
  • BNTX $123.29
  • Average True Range (ATR)
  • PHG 0.28
  • BNTX 4.89
  • MACD
  • PHG 0.09
  • BNTX 0.57
  • Stochastic Oscillator
  • PHG 10.51
  • BNTX 74.90

About PHG Koninklijke Philips N.V. NY Registry Shares

Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal care products.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.

Share on Social Networks: